(Q37582317)

English

Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study

scientific article published on 16 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Flossie Wong-Staal

10

object named as

Flossie Wong-Staal

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

4

object named as

David Wyles

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

1

object named as

Mark S Sulkowski

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

6

object named as

Gene D Morse

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

author name string

Minhee Kang

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Roy Matining

3

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Victoria A Johnson

5

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Valerianna Amorosa

7

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Debika Bhattacharya

8

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Kristine Coughlin

9

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Marshall J Glesby

11

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

AIDS Clinical Trials Group A5277 Protocol Team

12

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

language of work or name

0 references

publication date

16 September 2013

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

209

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

658-667

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Telaprevir for previously untreated chronic hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

A genetically humanized mouse model for hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Claudin association with CD81 defines hepatitis C virus entry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

23 August 2017

HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

6 September 2017

Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

6 September 2017

Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

14 September 2017

The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

25 June 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923538

1 September 2018

ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24041792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/INFDIS/JIT503

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37582317&oldid=1743616610"